Avalo Therapeutics (AVTX) Market Capitalization (2015 - 2026)
Avalo Therapeutics' Market Capitalization came in at $805.77 million for Q2 2026, compared with $54.08 million a year earlier and up 302.6% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Market Capitalization (2015 - 2026) Analysis & Trends
For FY2025, Avalo Therapeutics' Market Capitalization was $243.43 million, up 640.2% from FY2024.
- Market Capitalization carries a five-year compound annual growth rate of 4.2% (FY2020 to FY2025).
- Going back by year, Market Capitalization was $32.89 million in FY2024, $2.53 million in FY2023 (-94.7%), $47.57 million in FY2022 (-75.2%) and $191.9 million in FY2021 (-3.2%).
- The Q2 2026 figure represents the highest quarterly Market Capitalization in data going back to Q4 2015.
- The fastest year-over-year change in Market Capitalization over five years came in Q3 2024 (growth of 830.4%), and the weakest in Q4 2023 (a decline of 94.7%).
- Business Quant data shows AVTX's Market Capitalization at $200.13 million (Q1 2026), $243.43 million (Q4 2025) and $177.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Avalo Therapeutics | 533.82 Mn | -158.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 805.77 Mn |
| Mar 31, 2026 | 300.20 Mn |
| Dec 31, 2025 | 243.43 Mn |
| Sep 30, 2025 | 177.95 Mn |
| Jun 30, 2025 | 54.08 Mn |
| Mar 31, 2025 | 86.73 Mn |
| Dec 31, 2024 | 32.89 Mn |
| Sep 30, 2024 | 52.69 Mn |
| Jun 30, 2024 | 12.90 Mn |
| Mar 31, 2024 | 18.69 Mn |
| Dec 31, 2023 | 2.53 Mn |
| Sep 30, 2023 | 5.66 Mn |
| Jun 30, 2023 | 4.99 Mn |
| Mar 31, 2023 | 23.12 Mn |
| Dec 31, 2022 | 47.57 Mn |
| Sep 30, 2022 | 31.28 Mn |
| Jun 30, 2022 | 56.48 Mn |
| Mar 31, 2022 | 81.84 Mn |
| Dec 31, 2021 | 191.90 Mn |
| Sep 30, 2021 | 245.05 Mn |
API Access
Avalo Therapeutics Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();